Romeo Power, Inc.

2020 Q3 Form 10-Q Financial Statement

#000155837020013387 Filed on November 09, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2019 Q4 2019 Q3

Balance Sheet

Concept 2020 Q3 2019 Q4 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $246.0K $429.0K $1.400M
YoY Change -82.43%
Cash & Equivalents $246.0K $429.0K $2.295M
Short-Term Investments $0.00 $0.00
Other Short-Term Assets $100.0K $200.0K $200.0K
YoY Change -50.0%
Inventory $6.670M
Prepaid Expenses $1.616M
Receivables $307.0K
Other Receivables
Total Short-Term Assets $459.7K $15.02M $1.600M
YoY Change -71.27%
LONG-TERM ASSETS
Property, Plant & Equipment $6.573M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $232.3M
YoY Change
Other Assets $234.2M $1.296M $900.0K
YoY Change 25922.22%
Total Long-Term Assets $234.2M $17.56M $233.2M
YoY Change 0.42%
TOTAL ASSETS
Total Short-Term Assets $459.7K $15.02M $1.600M
Total Long-Term Assets $234.2M $17.56M $233.2M
Total Assets $234.6M $32.58M $234.8M
YoY Change -0.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.490K $5.811M $100.0K
YoY Change -93.51%
Accrued Expenses $400.0K $1.197M $300.0K
YoY Change 33.33%
Deferred Revenue $289.0K
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $5.000M
YoY Change
Total Short-Term Liabilities $358.9K $19.56M $1.000M
YoY Change -64.11%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $5.225M $0.00
YoY Change
Other Long-Term Liabilities $8.500M $268.0K $8.500M
YoY Change 0.0%
Total Long-Term Liabilities $8.500M $5.493M $8.500M
YoY Change 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $358.9K $19.56M $1.000M
Total Long-Term Liabilities $8.500M $5.493M $8.500M
Total Liabilities $8.901M $30.01M $9.500M
YoY Change -6.31%
SHAREHOLDERS EQUITY
Retained Earnings -$2.328M -$169.8M
YoY Change
Common Stock $7.327M $4.756M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$14.31M $2.573M $5.000M
YoY Change
Total Liabilities & Shareholders Equity $234.6M $32.58M $234.8M
YoY Change -0.07%

Cashflow Statement

Concept 2020 Q3 2019 Q4 2019 Q3

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q3 us-gaap Assets
Assets
234639206
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
dei Entity Registrant Name
EntityRegistrantName
RMG Acquisition Corp.
dei Entity Central Index Key
EntityCentralIndexKey
0001757932
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2020Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q3 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38795
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
83-2289787
dei Entity Address Address Line1
EntityAddressAddressLine1
50 West Street, Suite 40-C
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10006
dei City Area Code
CityAreaCode
212
dei Local Phone Number
LocalPhoneNumber
220-9503
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
dei Entity Shell Company
EntityShellCompany
true
CY2020Q3 us-gaap Cash
Cash
315502
CY2019Q4 us-gaap Cash
Cash
1175207
CY2020Q3 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
144188
CY2019Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
176403
CY2020Q3 us-gaap Assets Current
AssetsCurrent
459690
CY2019Q4 us-gaap Assets Current
AssetsCurrent
1351610
CY2020Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
234179516
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
233232730
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
133562
CY2020Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
202344
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
50000
CY2019Q4 us-gaap Assets
Assets
234584340
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
6490
CY2020Q3 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
150050
CY2019Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
200000
CY2019Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
88057
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
358884
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
471619
CY2020Q3 rmgun Deferred Legal Fees
DeferredLegalFees
450000
CY2019Q4 rmgun Deferred Legal Fees
DeferredLegalFees
450000
CY2020Q3 rmgun Deferred Underwriting Commissions
DeferredUnderwritingCommissions
8050000
CY2019Q4 rmgun Deferred Underwriting Commissions
DeferredUnderwritingCommissions
8050000
CY2020Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
41666
CY2020Q3 us-gaap Liabilities
Liabilities
8900550
CY2019Q4 us-gaap Liabilities
Liabilities
8971619
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
7326942
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
4749168
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2327604
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
250164
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
5000006
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
5000001
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
234639206
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
234584340
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
589274
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
210806
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1049053
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
668222
CY2020Q3 us-gaap Franchisor Costs
FranchisorCosts
50000
CY2019Q3 us-gaap Franchisor Costs
FranchisorCosts
50000
us-gaap Franchisor Costs
FranchisorCosts
150169
us-gaap Franchisor Costs
FranchisorCosts
150000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-639274
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-260806
us-gaap Operating Income Loss
OperatingIncomeLoss
-1199222
us-gaap Operating Income Loss
OperatingIncomeLoss
-818222
CY2020Q3 us-gaap Investment Income Net
InvestmentIncomeNet
13
CY2019Q3 us-gaap Investment Income Net
InvestmentIncomeNet
8839
us-gaap Investment Income Net
InvestmentIncomeNet
1111
us-gaap Investment Income Net
InvestmentIncomeNet
22725
CY2020Q3 rmgun Interest Earned On Restricted Cash Equivalents Held In Trust Account
InterestEarnedOnRestrictedCashEquivalentsHeldInTrustAccount
28551
rmgun Interest Earned On Restricted Cash Equivalents Held In Trust Account
InterestEarnedOnRestrictedCashEquivalentsHeldInTrustAccount
1153171
CY2019Q3 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
1142497
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-610814
us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
3299930
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-119129
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-491685
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
658150
CY2020Q3 us-gaap Interest Expense
InterestExpense
104
us-gaap Interest Expense
InterestExpense
104
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
890530
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-45044
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2504433
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
232380
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-170979
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
668514
us-gaap Net Income Loss
NetIncomeLoss
125935
us-gaap Net Income Loss
NetIncomeLoss
1835919
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
5000001
CY2020Q1 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
622370
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
622375
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
5000006
CY2020Q2 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
-4750
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-4755
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
5000001
CY2020Q3 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
-491690
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-491685
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
5000006
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
22445
CY2019Q1 rmgun Stock Issued During Period Value New Issues To Anchor Investors
StockIssuedDuringPeriodValueNewIssuesToAnchorInvestors
2313
CY2019Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
230000000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Ownshare Lending Arrangement Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts
-13448120
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
6900000
CY2019Q1 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
218801630
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
324994
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
5000002
CY2019Q2 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
852770
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
852775
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
5000007
CY2019Q3 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
658150
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
658150
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
5000007
us-gaap Net Income Loss
NetIncomeLoss
125935
us-gaap Net Income Loss
NetIncomeLoss
1835919
us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
3299930
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-115187
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
172974
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-127072
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
109264
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
152344
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
13000
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-40381
us-gaap Increase Decrease In Property And Other Taxes Payable
IncreaseDecreaseInPropertyAndOtherTaxesPayable
-49950
us-gaap Increase Decrease In Property And Other Taxes Payable
IncreaseDecreaseInPropertyAndOtherTaxesPayable
150000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-171029
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
591258
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
45415
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-813844
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
575947949
us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
346951000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-228996949
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
38501
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
113501
rmgun Forfeiture Of Class B Common Stock
ForfeitureOfClassBCommonStock
58
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2313
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
230000000
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
6900000
rmgun Deferred Underwriting Commissions In Connection With The Initial Public Offering
DeferredUnderwritingCommissionsInConnectionWithTheInitialPublicOffering
8050000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
87081
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
41666
us-gaap Payments For Repurchase Of Initial Public Offering
PaymentsForRepurchaseOfInitialPublicOffering
4758272
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
41666
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
232069041
rmgun Interest Income And Gain On Marketable Securities
InterestIncomeAndGainOnMarketableSecurities
3299930
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2258248
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
234407937
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
37044
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
234495018
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2295292
rmgun Offering Costs Included In Accrued Expenses
OfferingCostsIncludedInAccruedExpenses
100000
rmgun Non Cash Deferred Legal Fees In Connection With The Initial Public Offering
NonCashDeferredLegalFeesInConnectionWithTheInitialPublicOffering
150000
rmgun Reclassification Of Deferred Offering Costs To Equity
ReclassificationOfDeferredOfferingCostsToEquity
670220
us-gaap Stock Issued1
StockIssued1
125930
us-gaap Stock Issued1
StockIssued1
220312550
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
77257
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
230000000
rmgun Sale Of Units Price Per Unit
SaleOfUnitsPricePerUnit
10.00
rmgun Minimum Percentage Specified For Aggregate Fair Market Value Of Assets Held In Trust Account
MinimumPercentageSpecifiedForAggregateFairMarketValueOfAssetsHeldInTrustAccount
0.80
rmgun Threshold Percentage Of Outstanding Voting Securities In Business Combination
ThresholdPercentageOfOutstandingVotingSecuritiesInBusinessCombination
0.50
CY2020Q3 rmgun Amount Per Share Initially Held In Trust Account
AmountPerShareInitiallyHeldInTrustAccount
10.00
CY2020Q3 rmgun Minimum Amount Of Net Tangible Assets For Business Combination
MinimumAmountOfNetTangibleAssetsForBusinessCombination
5000001
rmgun Redemption Percentage Of Public Shares
RedemptionPercentageOfPublicShares
1
rmgun Amount Of Interest Released To Pay Dissolution Expenses
AmountOfInterestReleasedToPayDissolutionExpenses
100000
rmgun Operating Bank Account Held Outside Of Trust Account
OperatingBankAccountHeldOutsideOfTrustAccount
316000
us-gaap Investment Income Interest
InvestmentIncomeInterest
4200000
CY2020Q3 rmgun Interest Income On Restricted Cash Equivalents Held In Trust Account
InterestIncomeOnRestrictedCashEquivalentsHeldInTrustAccount
28551
CY2019Q3 rmgun Interest Income On Restricted Cash Equivalents Held In Trust Account
InterestIncomeOnRestrictedCashEquivalentsHeldInTrustAccount
5321
rmgun Interest Income On Restricted Cash Equivalents Held In Trust Account
InterestIncomeOnRestrictedCashEquivalentsHeldInTrustAccount
1153171
rmgun Interest Income On Restricted Cash Equivalents Held In Trust Account
InterestIncomeOnRestrictedCashEquivalentsHeldInTrustAccount
12025
CY2019Q3 rmgun Interest Income And Gain On Marketable Securities
InterestIncomeAndGainOnMarketableSecurities
1142497
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-491685
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
658150
us-gaap Net Income Loss
NetIncomeLoss
125935
us-gaap Net Income Loss
NetIncomeLoss
1835919
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The preparation of the financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Actual results could differ from those estimates.</p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Concentration of Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;">Financial instruments that potentially subject the Company to credit risk consist principally of cash, restricted cash equivalents held in the Trust Account, and marketable securities held in the Trust Account. Cash and restricted cash equivalents are maintained in accounts with financial institutions, which, at times may exceed the Federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts and management believes, based upon the quality of the financial institutions, that the credit risk with regard to these deposits is not significant. As of September 30, 2020 and December 31, 2019, the balance of restricted cash equivalents held in the Trust Account are </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">comprised entirely of an investment in a single money market fund which invests all of its assets in cash, U.S. Treasury bills, notes, and other obligations issued or guaranteed as to principal and interest by the U.S. Treasury. As of September 30, 2020 and December 31, 2019, the Company had no investments in marketable securities.</p>
CY2020Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2020Q3 us-gaap Marketable Securities
MarketableSecurities
0
CY2019Q4 us-gaap Marketable Securities
MarketableSecurities
0
CY2020Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
234200000
CY2019Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
233200000
CY2020Q3 us-gaap Cash
Cash
315502
CY2019Q4 us-gaap Cash
Cash
1175207
CY2020Q3 us-gaap Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
234179516
CY2019Q4 us-gaap Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
233232730
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
234495018
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
234407937
CY2020Q3 us-gaap Marketable Securities
MarketableSecurities
0
CY2019Q4 us-gaap Marketable Securities
MarketableSecurities
0
CY2020Q3 rmgun Deferred Offering Costs Related To Initial Public Offering
DeferredOfferingCostsRelatedToInitialPublicOffering
13400000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
50000
CY2020Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2020Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2019Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2019Q1 rmgun Unit Description For Initial Public Offering
UnitDescriptionForInitialPublicOffering
Each Unit consists of one share of Class A common stock and one-third of one redeemable warrant (“Public Warrant”). 
rmgun Operating Lease Rent Expense
OperatingLeaseRentExpense
8000
CY2020Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
38000
CY2019Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
32000
us-gaap Operating Lease Expense
OperatingLeaseExpense
61000
us-gaap Operating Lease Expense
OperatingLeaseExpense
61000
CY2020Q3 rmgun Deferred Legal Fees
DeferredLegalFees
450000
CY2019Q4 rmgun Deferred Legal Fees
DeferredLegalFees
450000
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.01
rmgun Number Of Days For Written Notice Of Redemption
NumberOfDaysForWrittenNoticeOfRedemption
P30D
rmgun Minimum Threshold Price Of Common Stock Specified To Send Notice Of Redemption To The Warrant Holders
MinimumThresholdPriceOfCommonStockSpecifiedToSendNoticeOfRedemptionToTheWarrantHolders
18.00
rmgun Number Of Days For Written Notice Of Redemption
NumberOfDaysForWrittenNoticeOfRedemption
P30D
rmgun Minimum Threshold Price Of Common Stock Specified To Send Notice Of Redemption To The Warrant Holders After Public Warrants Exercisable
MinimumThresholdPriceOfCommonStockSpecifiedToSendNoticeOfRedemptionToTheWarrantHoldersAfterPublicWarrantsExercisable
10.00
rmgun Maximum Issue Price Per Share For Capital Raised
MaximumIssuePricePerShareForCapitalRaised
9.20
CY2020Q3 rmgun Percentage Of Warrant Exercise Price Adjusted To Price Received In New Issuance
PercentageOfWarrantExercisePriceAdjustedToPriceReceivedInNewIssuance
1.15
CY2020Q3 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0

Files In Submission

Name View Source Status
0001558370-20-013387-index-headers.html Edgar Link pending
0001558370-20-013387-index.html Edgar Link pending
0001558370-20-013387.txt Edgar Link pending
0001558370-20-013387-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rmg-20200930.xsd Edgar Link pending
rmg-20200930x10q.htm Edgar Link pending
rmg-20200930x10q_htm.xml Edgar Link completed
rmg-20200930xex31d1.htm Edgar Link pending
rmg-20200930xex32d1.htm Edgar Link pending
rmg-20200930_cal.xml Edgar Link unprocessable
rmg-20200930_def.xml Edgar Link unprocessable
rmg-20200930_lab.xml Edgar Link unprocessable
rmg-20200930_pre.xml Edgar Link unprocessable
Show.js Edgar Link pending